Thiais, France

Chantal Carrez

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 10.3

ph-index = 3

Forward Citations = 168(Granted Patents)


Location History:

  • Thais, FR (2006)
  • Thias, FR (2011)
  • Thiais, FR (2005 - 2021)

Company Filing History:


Years Active: 2005-2021

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Chantal Carrez: Innovator in Antibody Research

Introduction

Chantal Carrez is a prominent inventor based in Thiais, France, known for her significant contributions to the field of antibody research. With a total of six patents to her name, she has made remarkable advancements in the development of therapeutic antibodies aimed at treating cancer.

Latest Patents

Among her latest patents are innovations related to anti-CD3 antibodies, anti-CD123 antibodies, and bispecific antibodies that specifically bind to CD3 and/or CD123. These inventions focus on antibody-like binding proteins that target CD3 and at least one additional antigen, such as CD123. Furthermore, her work includes the development of pharmaceutical compositions that incorporate these antibodies, which are intended for cancer treatment. Additionally, she has explored isoindole derivatives and their pharmaceutical applications, particularly as inhibitors of chaperone protein Hsp90 activities.

Career Highlights

Chantal Carrez has worked with notable companies in the pharmaceutical industry, including Aventis Pharma S.A. and Aventis Pharmaceuticals Inc. Her career reflects a commitment to advancing medical science through innovative research and development.

Collaborations

Throughout her career, Chantal has collaborated with esteemed colleagues, including Francois Clerc and Paul Joseph Cox. These partnerships have contributed to her success and the impact of her inventions in the field.

Conclusion

Chantal Carrez stands out as a leading inventor in the realm of antibody research, with a focus on developing innovative solutions for cancer treatment. Her contributions continue to shape the future of therapeutic antibodies and their applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…